Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to identify the highest oral dose of BMS-599626, a drug that is directed against EGFR and HER2 proteins, that can be given safely on a daily schedule of 21 days with a 7 d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06312137 · Non Small Cell Lung Cancer
NCT07586215 · Breast Cancer Metastatic
NCT07005128 · Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
NCT06467357 · Biliary Tract Cancer
NCT07489716 · Non-Small Cell Lung Cancer
Local Institution
Scottsdale, Arizona
Local Institution
Tucson, Arizona
Local Institution
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions